Chronic lymphocytic leukemia laboratory findings

Revision as of 00:54, 7 February 2019 by S.Singh (talk | contribs)
Jump to navigation Jump to search

Chronic lymphocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic lymphocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic lymphocytic leukemia laboratory findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic lymphocytic leukemia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic lymphocytic leukemia laboratory findings

CDC on Chronic lymphocytic leukemia laboratory findings

Chronic lymphocytic leukemia laboratory findings in the news

Blogs on Chronic lymphocytic leukemia laboratory findings

Directions to Hospitals Treating Chronic lymphocytic leukemia

Risk calculators and risk factors for Chronic lymphocytic leukemia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [3]

Overview

Laboratory findings consistent with the diagnosis of chronic lymphocytic leukemia include abnormal complete blood count, immunohistochemistry, and electrophoresis. Monoclonality of kappa and lambda producing B cells is a key diagnostic feature among patients with chronic lymphocytic leukemia.

Laboratory Findings

Complete Blood Count

  • Absolute lymphocytosis ≥5000 B-lymphocytes/µL X ≥ 3 months
  • Decreased hemoglobin concentration
  • Decreased platelets count

Blood Smear

  • Presence of smudge cells

Metabolic Panel

Quantitative Immunoglobulin Assay

Electrophoresis

  • Monoclonality of kappa and lambda producing B cells is a key diagnostic feature among patients with chronic lymphocytic leukemia.

Immunohistochemistry

  • Chronic lymphocytic leukemia cells typically express CD19, CD20, CD23, and CD5 on the cell surface.

Peripheral Blood Cytogenetics

Peripheral blood cytogenetics and FISH determine prognosis in patients with CLL. The most important prognostic feature is the presence of absence of del(17p), which leads to the loss of TP53, a tumor suppressor gene. Presence of del(13q) is a favorable feature. Presence of del(11q) is an adverse prognostic feature.

References